$2.74 Billion is the total value of BVF INC/IL's 72 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 17.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $465,259,965 | +103.7% | 21,751,284 | 0.0% | 17.01% | +76.4% | ||
| KYMR | Buy | KYMERA THERAPEUTICS INC | $140,416,689 | +19.9% | 4,739,004 | +1.0% | 5.13% | +3.8% |
| AXSM | Buy | AXSOME THERAPEUTICS INC | $131,446,248 | -2.9% | 2,131,100 | +21.4% | 4.80% | -15.9% |
| RVMD | Buy | REVOLUTION MEDICINES INC | $107,338,036 | +38.4% | 4,955,588 | +52.2% | 3.92% | +19.9% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $91,521,598 | +116.0% | 2,560,761 | +128.3% | 3.35% | +87.1% |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $86,845,700 | – | 3,775,900 | +100.0% | 3.18% | – |
| GLPG | Buy | GALAPAGOS NVspon adr | $83,659,812 | +1785.1% | 2,165,109 | +2065.1% | 3.06% | +1535.3% |
| KURA | Buy | KURA ONCOLOGY INC | $82,319,922 | +74.5% | 6,730,983 | +77.1% | 3.01% | +51.1% |
| RPTX | REPARE THERAPEUTICS INC | $81,593,162 | -33.1% | 8,291,988 | 0.0% | 2.98% | -42.1% | |
| PNT | Buy | POINT BIOPHARMA GLOBAL INC | $76,798,448 | +14.8% | 10,563,748 | +15.1% | 2.81% | -0.6% |
| XOMA | Buy | XOMA CORP DEL | $76,708,315 | +15.4% | 3,633,743 | +0.6% | 2.80% | 0.0% |
| GHRS | GH RESEARCH PLCordinary shares | $74,108,512 | -17.4% | 9,275,158 | 0.0% | 2.71% | -28.4% | |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | $68,887,429 | -22.6% | 4,007,413 | 0.0% | 2.52% | -33.0% | |
| XENE | Buy | XENON PHARMACEUTICALS INC | $65,422,617 | +30.5% | 1,827,958 | +43.8% | 2.39% | +13.1% |
| MRUS | MERUS N V | $54,802,928 | +18.9% | 2,978,420 | 0.0% | 2.00% | +3.0% | |
| ZYMEWORKS INC | $53,064,800 | +15.0% | 5,870,000 | 0.0% | 1.94% | -0.4% | ||
| Buy | TYRA BIOSCIENCES INC | $52,060,292 | +177.1% | 3,239,595 | +31.0% | 1.90% | +140.0% | |
| RLAY | Sell | RELAY THERAPEUTICS INC | $51,394,981 | -11.2% | 3,120,521 | -19.5% | 1.88% | -23.1% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $45,264,321 | +22.6% | 2,143,197 | +47.7% | 1.66% | +6.2% |
| CRNX | CRINETICS PHARMACEUTICALS IN | $43,950,005 | -12.2% | 2,736,613 | 0.0% | 1.61% | -24.0% | |
| New | STRUCTURE THERAPEUTICS INCsponsored ads | $41,632,500 | – | 1,750,000 | +100.0% | 1.52% | – | |
| IMVT | IMMUNOVANT INC | $39,721,110 | -12.6% | 2,561,000 | 0.0% | 1.45% | -24.3% | |
| LXRX | LEXICON PHARMACEUTICALS INC | $39,242,505 | +27.2% | 16,149,179 | 0.0% | 1.44% | +10.2% | |
| REPL | Buy | REPLIMUNE GROUP INC | $37,846,016 | -8.6% | 2,143,036 | +40.7% | 1.38% | -20.9% |
| CTIC | CTI BIOPHARMA CORP | $37,014,688 | -30.1% | 8,813,021 | 0.0% | 1.35% | -39.5% | |
| CNTA | Buy | CENTESSA PHARMACEUTICALS PLCsponsored ads | $36,279,378 | +69.7% | 9,423,215 | +36.7% | 1.33% | +47.0% |
| IDYA | Buy | IDEAYA BIOSCIENCES INC | $33,708,372 | -15.9% | 2,455,089 | +11.3% | 1.23% | -27.1% |
| CGEM | Sell | CULLINAN ONCOLOGY INC | $32,702,251 | -58.7% | 3,196,701 | -57.4% | 1.20% | -64.3% |
| RAIN | RAIN ONCOLOGY INC | $30,823,611 | +9.2% | 3,526,729 | 0.0% | 1.13% | -5.4% | |
| ETNB | New | 89BIO INC | $28,116,925 | – | 1,846,154 | +100.0% | 1.03% | – |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $27,190,013 | -47.3% | 3,360,941 | +2.6% | 0.99% | -54.4% |
| ALLK | Buy | ALLAKOS INC | $26,968,099 | -36.0% | 6,060,247 | +21.0% | 0.99% | -44.6% |
| OLMA | OLEMA PHARMACEUTICALS INC | $26,411,915 | +41.6% | 7,611,503 | 0.0% | 0.96% | +22.6% | |
| EPIX | ESSA PHARMA INC | $25,983,428 | +17.9% | 8,748,629 | 0.0% | 0.95% | +2.2% | |
| ITOS | ITEOS THERAPEUTICS INC | $24,645,464 | -30.3% | 1,810,835 | 0.0% | 0.90% | -39.7% | |
| NEWAMSTERDAM PHARMA COMPANYordinary shares | $20,454,981 | +27.8% | 1,521,948 | 0.0% | 0.75% | +10.7% | ||
| JANX | Buy | JANUX THERAPEUTICS INC | $19,186,692 | -0.9% | 1,585,677 | +7.8% | 0.70% | -14.2% |
| THIRD HARMONIC BIO INC | $17,987,644 | -4.2% | 4,365,933 | 0.0% | 0.66% | -16.9% | ||
| CALT | CALLIDITAS THERAPEUTICS ABsponsered ads | $17,962,500 | +36.6% | 750,000 | 0.0% | 0.66% | +18.4% | |
| New | JASPER THERAPEUTICS INC | $17,919,000 | – | 9,900,000 | +100.0% | 0.66% | – | |
| VIGIL NEUROSCIENCE INC | $17,755,467 | -21.7% | 1,813,633 | 0.0% | 0.65% | -32.2% | ||
| OVID | OVID THERAPEUTICS INC | $17,675,712 | +38.7% | 6,851,051 | 0.0% | 0.65% | +20.1% | |
| ACIU | AC IMMUNE SA | $17,382,407 | +14.7% | 7,428,379 | 0.0% | 0.64% | -0.8% | |
| STRO | SUTRO BIOPHARMA INC | $15,467,511 | -42.8% | 3,347,946 | 0.0% | 0.56% | -50.5% | |
| AN2 THERAPEUTICS INC | $15,436,315 | +3.6% | 1,563,963 | 0.0% | 0.56% | -10.3% | ||
| GLYC | GLYCOMIMETICS INC | $12,025,770 | -58.4% | 9,544,262 | 0.0% | 0.44% | -63.9% | |
| IKNA | Buy | IKENA ONCOLOGY INC | $10,933,616 | +64.2% | 3,169,164 | +26.6% | 0.40% | +42.3% |
| CTMX | CYTOMX THERAPEUTICS INC | $9,959,660 | -5.6% | 6,595,801 | 0.0% | 0.36% | -18.2% | |
| ARAV | ARAVIVE INC | $9,568,428 | +51.5% | 4,784,214 | 0.0% | 0.35% | +31.1% | |
| VERV | VERVE THERAPEUTICS INC | $9,373,000 | -25.5% | 650,000 | 0.0% | 0.34% | -35.4% | |
| SLN | SILENCE THERAPEUTICS PLCads | $9,352,179 | -59.3% | 1,508,416 | 0.0% | 0.34% | -64.8% | |
| CDTX | CIDARA THERAPEUTICS INC | $8,713,631 | +67.9% | 6,861,127 | 0.0% | 0.32% | +45.7% | |
| NLSP | NLS PHARMACEUTICS LTD | $8,678,160 | +17.1% | 5,747,126 | 0.0% | 0.32% | +1.3% | |
| VSTM | VERASTEM INC | $7,898,207 | +3.2% | 19,022,656 | 0.0% | 0.29% | -10.5% | |
| ALPN | Sell | ALPINE IMMUNE SCIENCES INC | $6,626,377 | -20.6% | 858,339 | -24.4% | 0.24% | -31.2% |
| VIRX | VIRACTA THERAPEUTICS INC | $5,747,313 | +8.9% | 3,614,662 | 0.0% | 0.21% | -5.8% | |
| ELDN | ELEDON PHARMACEUTICALS INC | $5,491,036 | +1.7% | 2,326,710 | 0.0% | 0.20% | -11.8% | |
| PIRS | PIERIS PHARMACEUTICALS INC | $4,958,392 | -6.2% | 5,080,320 | 0.0% | 0.18% | -18.8% | |
| ELEV | ELEVATION ONCOLOGY INC | $4,393,180 | +100.5% | 2,312,200 | 0.0% | 0.16% | +75.0% | |
| VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $4,273,920 | -88.2% | 168,000 | -86.4% | 0.16% | -89.8% |
| HILLEVAX INC | $4,109,011 | -1.2% | 248,579 | 0.0% | 0.15% | -14.8% | ||
| MOLN | MOLECULAR PARTNERS AGads | $2,659,326 | -7.4% | 443,221 | 0.0% | 0.10% | -19.8% | |
| IVA | INVENTIVA SAads | $2,497,186 | -17.8% | 686,040 | 0.0% | 0.09% | -28.9% | |
| Sell | AADI BIOSCIENCE INC | $2,303,804 | -68.1% | 318,205 | -43.4% | 0.08% | -72.4% | |
| MTEM | MOLECULAR TEMPLATES INC | $1,898,195 | +15.8% | 4,996,565 | 0.0% | 0.07% | 0.0% | |
| IMUX | IMMUNIC INC | $1,712,643 | +6.4% | 1,149,425 | 0.0% | 0.06% | -7.4% | |
| CRVS | CORVUS PHARMACEUTICALS INC | $1,247,562 | +7.1% | 1,370,947 | 0.0% | 0.05% | -6.1% | |
| INFI | INFINITY PHARMACEUTICALS INC | $1,016,583 | -71.2% | 6,353,645 | 0.0% | 0.04% | -75.2% | |
| ANGN | ANGION BIOMEDICA CORP | $621,352 | -28.5% | 1,071,297 | 0.0% | 0.02% | -37.8% | |
| GLMD | Sell | GALMED PHARMACEUTICALS LTD | $574,818 | -33.9% | 1,347,755 | -22.5% | 0.02% | -43.2% |
| RZLT | REZOLUTE INC | $366,365 | -7.2% | 190,815 | 0.0% | 0.01% | -23.5% | |
| BIONOMICS LIMITEDads | $210,525 | -43.6% | 80,971 | 0.0% | 0.01% | -50.0% | ||
| GBIO | Exit | GENERATION BIO CO | $0 | – | -102,900 | -100.0% | -0.02% | – |
| Exit | AILERON THERAPEUTICS INC | $0 | – | -236,835 | -100.0% | -0.02% | – | |
| XFOR | Exit | X4 PHARMACEUTICALS INC | $0 | – | -1,347,650 | -100.0% | -0.06% | – |
| Exit | CALITHERA BIOSCIENCES INC | $0 | – | -464,742 | -100.0% | -0.06% | – | |
| SELB | Exit | SELECTA BIOSCIENCES INC | $0 | – | -1,391,749 | -100.0% | -0.07% | – |
| Exit | PYXIS ONCOLOGY INC | $0 | – | -2,938,851 | -100.0% | -0.17% | – | |
| COGT | Exit | COGENT BIOSCIENCES INC | $0 | – | -984,824 | -100.0% | -0.48% | – |
| ANNX | Exit | ANNEXON INC | $0 | – | -3,780,694 | -100.0% | -0.82% | – |
| CNCE | Exit | CONCERT PHARMACEUTICALS INC | $0 | – | -3,629,000 | -100.0% | -0.89% | – |
| RCUS | Exit | ARCUS BIOSCIENCES INC | $0 | – | -2,303,520 | -100.0% | -2.01% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| XENON PHARMACEUTICALS INC | 36 | Q3 2023 | 4.7% |
| PIERIS PHARMACEUTICALS INC | 30 | Q3 2023 | 2.8% |
| CYTOKINETICS INC | 29 | Q4 2020 | 11.8% |
| INFINITY PHARMACEUTICALS INC | 29 | Q2 2023 | 4.3% |
| XOMA CORP DEL | 28 | Q3 2023 | 7.3% |
| ARQULE INC | 27 | Q4 2019 | 4.8% |
| CHEMOCENTRYX INC | 26 | Q3 2019 | 13.8% |
| CYTOMX THERAPEUTICS INC | 26 | Q3 2023 | 5.3% |
| CORVUS PHARMACEUTICALS INC | 26 | Q3 2023 | 2.3% |
| ARRAY BIOPHARMA INC | 25 | Q2 2019 | 14.5% |
View BVF INC/IL's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 4 | 2024-01-29 |
| 3 | 2024-01-26 |
| 4 | 2024-01-09 |
| 4 | 2023-12-20 |
| 4 | 2023-11-17 |
| 13F-HR | 2023-11-14 |
| 3 | 2023-11-13 |
| 3 | 2023-11-06 |
| 4 | 2023-11-06 |
View BVF INC/IL's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.